ClinicalTrials.gg
CompletedNCT06659887Updated Oct 13, 2026

Different Flow Rates on Gas Exchange in Children During Apnea

An interventional study of nasal cannula in Apnea, sponsored by Yasser S Mostafa, MD. Completed at 1 site in Egypt. Open to participants aged 1 Year to 6 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Yasser S Mostafa, MD · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 13, 2026Start date movedPrimary outcomes revised+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
1 Year to 6 Years
Sex
All
01

Study summary

Background: Children desaturate rapidly during apnea following anesthetic induction. The optimal apneic oxygenation flow rate and its effect on CO2 accumulation remain unclear.

Objective: To compare nasal oxygen at 2, 4, and 8 L/min on the rise in arterial partial pressure of CO2 (PaCO2) between minutes 2 and 3 of apnea (primary outcome), oxygenation, and safety in anesthetized children.

Read the detailed description

Introduction Patients undergoing general anesthesia with neuromuscular blockade experience a period of apnea between cessation of mask ventilation and initiation of mechanical ventilation. This interval is particularly critical in infants and toddlers, who are prone to rapid desaturation because of higher oxygen consumption and lower functional residual capacity than older children and adults [1]. Accordingly, hypoxemia during induction and airway manipulation is associated with an increased incidence of postoperative complications and serious adverse events, including death [2,3].

Apneic oxygenation refers to the continuous insufflation of oxygen into the airway during apnea [4]. Several studies have shown that this approach effectively maintains oxygenation and reduces the risk of hypoxemia during tracheal intubation [5,6]. An ongoing challenge in pediatric anesthesia is to ensure adequate oxygenation while limiting lung volume loss and carbon dioxide accumulation during apnea, particularly during airway manipulation. Therefore, techniques that extend the duration of safe apnea without introducing additional risks are of considerable clinical relevance [7]. Accordingly, apneic oxygenation has gained attention as an adjunctive technique, with similar benefits reported in children using both low-flow and high-flow nasal oxygen, although pediatric data remain more limited [8].

Multiple studies have examined low-flow apneic oxygenation in children, showing that it reduces the incidence of hypoxemia and extends the duration of safe apnea, in some reports by up to several minutes, compared with no apneic oxygenation. Comparative data on CO2 kinetics across different low-flow rates in children are limited [9-11]. Therefore, this study aimed to examine the effect of different flow oxygen rates applied during a standardized 6-minute period of apnea on the increase in arterial partial pressure of CO2 (PaCO2) in anesthetized, paralyzed children.

Sample size No previous data were available for the primary outcome, the rise in PaCO₂ between the 2nd and 3rd minutes of apnea (ΔPaCO₂, mmHg), so a pilot study of five children per group was performed. These pilot children were a separate, non-randomized cohort and were excluded from the modified intention-to-treat analysis. The mean ± SD ΔPaCO₂ was 4.2 ± 1.6, 3.4 ± 1.5 and 2.8 ± 1.4 mmHg at 2, 4 and 8 L/min. The largest difference (2 vs 8 L/min) was 1.4 mmHg, a one-third reduction, considered clinically meaningful as it would delay hypercapnia and respiratory acidosis during apnea; the pooled SD for these two groups was 1.5 mmHg (Cohen's d = 0.93). For three pairwise comparisons with 1:1:1 allocation, a two-sided alpha of 0.0167 (0.05/3) and 80% power, at least 26 children per group were required (independent-samples t-test, G*Power 3.1.9.7), used as an approximation for the three-group ANOVA design. Allowing for 15% loss of data, 30 children were enrolled per group (90 total).

02

Conditions studied

  • Apnea

Browse trials for

Keywords

  • Low flow rate
  • Children
  • Gas exchange
03

In context

Apnea

283 studies on the registry are indexed under Apnea; 55 are open to participants now.

This study's enrollment of 90 is above the median of 60 across 196 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

Yasser S Mostafa, MD is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 6 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 1 to 6 years old weighting 10-20 kg.
  • (ASA) physical status I or II.
  • Children will be scheduled for elective surgery under general anesthesia.

Exclusion criteria

Exclusion Criteria:

  • Parent refusal
  • Patient required nasal intubation
  • Children with a cardio-respiratory disease like asthma or recent upper respiratory infection.
  • Anemia.
  • Obstructive sleep apnea, sepsis.
  • Children prone to hypoxia or hypercarbia, and upper airway obstruction.
  • Children reported to have nasal obstruction .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Active comparator
    Low group

    Low flow 100% O2 AT 2 L/min

    Device: nasal cannula

  • Active comparator
    Moderate group

    Low flow 100% O2 AT 4 L/min

    Device: nasal cannula

  • Active comparator
    High group

    Low flow 100% O2 AT 8 L/min

    Device: nasal cannula

Interventions

  • Devicenasal cannula

    After induction, bag-mask ventilation with 100% oxygen and flow rates of 6 L/ min will be carried out until the expired oxygen concentration will be \>90%, saturation of oxygen was 100%, and end tidal carbon dioxide was 30-40 mmHg. Once this will be reached, bag-mask ventilation will be stopped and apneic oxygenation will be initiated for 3 minutes

    Also known as: oxygen nasal cannula

06

What researchers measure

Primary outcomes

  1. rise of arterial pressure of carbon dioxide

    mmHg

    Time frame: between 120s and 180s time points of apnea

Secondary outcomes

  1. Time to oxygen desaturation

    below 95%

    Time frame: 5 seconds after the onset of apnea

  2. Number of patients reached 6 minutes of apnea

    Count number of patients in each group

    Time frame: 1 minute after end of apneic oxygenation

  3. Pressure difference between the end-tidal carbon dioxide and the arterial carbon dioxide

    mmHg

    Time frame: Between the end of apnea and the preceding blood gas

  4. Mean difference in arterial pressure of oxygen

    mmHg

    Time frame: at the beginning of apnea

  5. Mean difference in arterial pressure of oxygen

    mmHg

    Time frame: at the end of apnea time

  6. Lowest recorded oxygen saturation

    in percentage (%)

    Time frame: throughout the apneic oxygenation

  7. Heart rate

    beat/minute

    Time frame: Before anaesthetizing child

  8. Mean arterial blood pressure

    mmHg

    Time frame: Before anaesthetizing child

  9. Heart rate

    beat/minute

    Time frame: During apnea time

  10. Mean arterial blood pressure

    mmHg

    Time frame: During apnea time

  11. Occurence of sore throat

    Yes or no

    Time frame: in first postoperative day

Other outcomes

  1. Age

    Years

    Time frame: 1 hour preoperatively

  2. Weight

    Kilogram

    Time frame: 1 hour preoperatively

07

Study locations

1 site
  • Fayoum University Hospital
    Al Fayyum, Faiyum Governorate 63514, Egypt
08

References and documents

Publications

  • Li S, Hsieh TC, Rehder KJ, Nett S, Kamat P, Napolitano N, Turner DA, Adu-Darko M, Jarvis JD, Krawiec C, Derbyshire AT, Meyer K, Giuliano JS Jr, Tala J, Tarquinio K, Ruppe MD, Sanders RC Jr, Pinto M, Howell JD, Parker MM, Nuthall G, Shepherd M, Emeriaud G, Nagai Y, Saito O, Lee JH, Simon DW, Orioles A, Walson K, Vanderford P, Shenoi A, Lee A, Bird GL, Miksa M, Graciano AL, Bain J, Skippen PW, Polikoff LA, Nadkarni V, Nishisaki A; for National Emergency Airway Registry for Children (NEAR4KIDS) and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Frequency of Desaturation and Association With Hemodynamic Adverse Events During Tracheal Intubations in PICUs. Pediatr Crit Care Med. 2018 Jan;19(1):e41-e50. doi: 10.1097/PCC.0000000000001384. PubMed 29210925 ↗
  • Parker MM, Nuthall G, Brown C 3rd, Biagas K, Napolitano N, Polikoff LA, Simon D, Miksa M, Gradidge E, Lee JH, Krishna AS, Tellez D, Bird GL, Rehder KJ, Turner DA, Adu-Darko M, Nett ST, Derbyshire AT, Meyer K, Giuliano J Jr, Owen EB, Sullivan JE, Tarquinio K, Kamat P, Sanders RC Jr, Pinto M, Bysani GK, Emeriaud G, Nagai Y, McCarthy MA, Walson KH, Vanderford P, Lee A, Bain J, Skippen P, Breuer R, Tallent S, Nadkarni V, Nishisaki A; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Relationship Between Adverse Tracheal Intubation Associated Events and PICU Outcomes. Pediatr Crit Care Med. 2017 Apr;18(4):310-318. doi: 10.1097/PCC.0000000000001074. PubMed 28198754 ↗
  • Dias R, Dave N, Chhabria R, Shah H, Garasia M. A randomised comparative study of Miller laryngoscope blade versus Oxiport(R) Miller laryngoscope blade for neonatal and infant intubations. Indian J Anaesth. 2017 May;61(5):404-409. doi: 10.4103/ija.IJA_86_17. PubMed 28584350 ↗

Individual participant data

Plan to share: No

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in May 2026, 18 months.

Of 69 non-industry interventional studies with no phase under Apnea, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's 18 months is close to that.

Counting every sponsor, half of 78 studies reached it within 17 months; a quarter within 8 and three quarters within 35.

Start moved once since we started tracking on Sep 25, 2026: Oct 2024 → Nov 2024, on Oct 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2024
First posted
Oct 26, 2024
StartActual
Nov 1, 2024was Oct 2024
Primary completionActual
May 1, 2026
CompletionActual
Jun 1, 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 1, 2024→Nov 1, 2024
Oct 13, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time framerise of arterial pressure of carbon dioxidebetween 60s and 180s time points of apnea → between 120s and 180s time points of apnea
Oct 7, 2026
Registered
First appeared on the registry
Sep 30, 2026
Show all 3 updates
  1. Oct 13, 2026
    Start date Oct 1, 2024→Nov 1, 2024
  2. Oct 7, 2026
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time framerise of arterial pressure of carbon dioxidebetween 60s and 180s time points of apnea → between 120s and 180s time points of apnea
    + 2 other changes: verification date and description
  3. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06659887
Lead sponsor
Yasser S Mostafa, MD
Responsible party
Yasser S Mostafa, MD (Lecturer of anesthesia, Fayoum University Hospital) — Sponsor-investigator
First posted
Oct 26, 2024
Start date
Nov 1, 2024
Primary completion
May 1, 2026
Completion
Jun 1, 2026
Last update
Oct 13, 2026

Study contacts

Safaa G Ragab, MD
study director · Fayoum University
Ahmed A Lotfy, MD
study director · Fayoum University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion